Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
130.00    -0.90 (-0.69%)
Bid:
129.50
Ask:
129.90
Spread: 0.40 (0.309%)
Market Cap: £328.76m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Board Appointment

29 Apr 2021 07:00

RNS Number : 9923W
Marshalls PLC
29 April 2021
 

29 April 2021

 

Marshalls plc

(the "Company" or "Marshalls")

 

Board Appointment

 

Justin Lockwood appointed as CFO

 

Marshalls plc, the specialist landscape products group, is pleased to announce the appointment of Justin Lockwood to the Board as Chief Financial Officer.

 

Justin is currently the Chief Financial Officer of International Personal Finance plc. He joined them in 2010 and held a number of senior finance roles prior to his appointment as CFO in 2017. Justin brings extensive experience of all aspects of financial management in large publicly listed companies.

 

Prior to International Personal Finance plc, Justin worked for Associated British Ports for four years in a senior finance role. His first role in industry was with Marshalls, between 2002 and 2006, where he worked in a variety of business unit and head office roles, including as finance director of Marshalls Clay Products before its disposal to Hanson plc. Justin is a chartered accountant, having qualified with PwC where he spent the first 10 years of his career.

 

Justin succeeds Jack Clarke who stepped down from the Board, and as Group Finance Director, on 31 March 2021. His appointment will take effect at a date to be agreed once his departure date from International Personal Finance plc has been finalised.

 

Martyn Coffey, CEO of Marshalls commented:

 

"We're delighted that Justin is joining the business. His rich, cross-sector experience, which includes time with Marshalls earlier in his career, will be an asset to the Board and help us capitalise on future growth opportunities and deliver our strategic objectives. In Justin, we're confident we've found an outstanding successor to Jack Clarke, who made a significant contribution to the sustained growth of Marshalls during his time with us."

 

Justin Lockwood commented:

 

"Marshalls is an exceptional business with strong heritage and a clear strategic vision. I'm delighted to be joining and look forward to working with Martyn, the Board and all of Marshalls' very dedicated colleagues"

 

There are no disclosures required pursuant to Listing Rule 9.6.13.

 

- Ends -

 

The information communicated in this announcement is inside information.

 

Enquiries:

 

Martyn Coffey, Chief Executive

Marshalls plc

+44 (0)1422 314777

Shiv Sibal, Company Secretary

Marshalls plc

+44 (0)1422 314767

Andrew Jaques

MHP Communications

+44 (0)20 3128 8540

Charlie Barker

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWVARAWUSUUR
Date   Source Headline
14th Jul 202211:51 amRNSDirector/PDMR Shareholding
12th Jul 20227:00 amRNSTrading Statement
11th May 20221:34 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
10th May 20223:14 pmRNSDirector/PDMR Shareholding
10th May 20223:02 pmRNSDirector/PDMR Shareholding
5th May 20229:19 amRNSHolding(s) in Company
3rd May 20224:20 pmRNSHolding(s) in Company
3rd May 20223:09 pmRNSDirector/PDMR Shareholding
3rd May 20223:08 pmRNSDirector/PDMR Shareholding
3rd May 20223:07 pmRNSDirector/PDMR Shareholding
3rd May 20223:06 pmRNSDirector/PDMR Shareholding
3rd May 20223:03 pmRNSDirector/PDMR Shareholding
3rd May 20223:02 pmRNSDirector/PDMR Shareholding
3rd May 20223:01 pmRNSDirector/PDMR Shareholding
3rd May 20223:00 pmRNSDirector/PDMR Shareholding
3rd May 20222:57 pmRNSDirector/PDMR Shareholding
3rd May 20222:53 pmRNSDirector/PDMR Shareholding
3rd May 20229:54 amRNSHolding(s) in Company
29th Apr 20228:25 amRNSTotal Voting Rights
29th Apr 20228:05 amRNSAcquisition
28th Apr 202211:51 amRNSAcquisition
27th Apr 202210:01 amRNSDirector Declaration
7th Apr 20221:50 pmRNSPublication of Prospectus
7th Apr 20227:00 amRNSResults of Accelerated Bookbuild
6th Apr 20224:46 pmRNSProposed Acquisition of Marley Group & Fundraising
5th Apr 20228:58 amRNSAnnual Financial Report
4th Apr 20228:54 amRNSHolding(s) in Company
18th Mar 20223:44 pmRNSDirector/PDMR Shareholding
18th Mar 20223:43 pmRNSDirector/PDMR Shareholding
17th Mar 20227:15 amRNSBoard Appointment
17th Mar 20227:00 amRNSFinal Results
4th Mar 20229:48 amRNSDirector/PDMR Shareholding
4th Feb 20222:42 pmRNSDirector/PDMR Shareholding
31st Jan 202210:29 amRNSDirector Declaration
18th Jan 20227:00 amRNSTrading Statement
5th Jan 20222:31 pmRNSDirector/PDMR Shareholding
14th Dec 202111:26 amRNSDirectorate Change
6th Dec 202110:51 amRNSDirector/PDMR Shareholding
11th Nov 20212:58 pmRNSDirector/PDMR Shareholding
5th Oct 202110:32 amRNSDirector/PDMR Shareholding
1st Oct 20214:03 pmRNSDirector/PDMR Shareholding
29th Sep 20214:09 pmRNSDirector/PDMR Shareholding
21st Sep 20213:54 pmRNSDirector/PDMR Shareholding
21st Sep 20213:53 pmRNSDirector/PDMR Shareholding
7th Sep 20212:06 pmRNSDirector/PDMR Shareholding
20th Aug 20214:57 pmRNSHolding(s) in Company
19th Aug 20217:00 amRNSHalf-year Report
4th Aug 202111:57 amRNSDirector Declaration
19th Jul 20216:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.